PYPD (PolyPid Ltd.) Pangali Forward P/E

Logo perusahaan publik PolyPid (PYPD)

High surgeon confidence in PolyPid Ltd. (PYPD) prolonged antibiotic therapy systems stabilizes costs, and the company's expected P/E ratio shown on this GURU.Markets chart confirms this, where 0.00 is the current value of the metric. Business efficiency is based on PLEX robotic packaging, automated synthesis of new drugs, and mandatory medical oversight of clinical trials.

Rasio rega marang bathi mangsa ngarep: PolyPid Ltd. (PYPD) kanggo 04.07.2022 - 10.11.2026

Ringkesan rincian data analitis PolyPid Limited (PYPD)

- rega saiki lan proyeksi nilai saham:
Kutipan saham PolyPid Ltd.|PYPD - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Kapitalisasi pasar PolyPid Ltd|PYPD - Rega Tumbas Perusahaan
- informasi kapitalisasi buku:
Aset Bersih saben Siji Saham PolyPid|PYPD - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku polypid.com|PYPD - Nilai Total Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal PolyPid Ltd.|PYPD - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal PolyPid Ltd.|PYPD - Gunggung utang perusahaan|Utang marang nilai buku PolyPid Ltd|PYPD - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan PolyPid|Likuiditas cepet polypid.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
PYPD - Penghasilan resik perusahaan|Bathi sing dikarepake PolyPid Ltd.|PYPD - Pangali rega marang bathi|Rega marang bathi mangsa ngarep PolyPid Ltd.|PYPD - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PolyPid Ltd|PYPD - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan PolyPid|PYPD - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan polypid.com|PYPD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep PolyPid Ltd.
Analisis fundamental perusahaan:PolyPid PYPD
Produk merek PolyPid Limited

The metric is calculated as the ratio of current market capitalization to expected net income, reflecting the market valuation of future cash flows adjusted for operating expenses. Guaranteed capacity utilization for the production of anti-infective agents stabilizes projected revenues, allowing the 12-month forward P/E of PolyPid Ltd. (PYPD) to assess the asset's fair value and the risks of overpayment.

Pesaing wigati

Prakiraan rega marang bathi SMMT (Summit Therapeutics Inc.)|MRNA (Moderna Inc) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E PCVX (Vaxcyte Corp)|Kapitalisasi marang proyeksi bathi Tarsus Corp (TARS)|CRMD - Rega marang bathi mangsa ngarep|MCRB (serestherapeutics.com) - Rasio rega marang bathi mangsa ngarep|SPRO: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake SCYX (SCYNEXIS)|ANTX (AN2 Therapeutics Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi YS Biopharma Co., Ltd. LSB|Pangali Forward P/E ITRM|Prakiraan rega marang bathi biomx.com PHGE|Soligenix - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep SXTP (60 Degrees Pharmaceuticals Inc.)|Oragenics - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi OpGen Corporation OPGN